Healthcare provider profile · identity verified

Benjamin Fano, MD

Internal Medicine · MCALLEN, TX · NPI 1952495400

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	395	119
Amlodipine Besylate	Amlodipine Besylate	208	62
Losartan Potassium	Losartan Potassium	187	59
Levothyroxine Sodium	Levothyroxine Sodium	155	41
Gabapentin	Gabapentin	153	33
Pantoprazole Sodium	Pantoprazole Sodium	134	58
Memantine Hcl	Memantine Hcl	130	16
Metoprolol Tartrate	Metoprolol Tartrate	130	41
Metformin Hcl	Metformin Hcl	129	43
Rosuvastatin Calcium	Rosuvastatin Calcium	125	35
Clopidogrel	Clopidogrel Bisulfate	123	42
Donepezil Hcl	Donepezil Hcl	111	21
Furosemide	Furosemide	110	27
Metoprolol Succinate	Metoprolol Succinate	109	31
Lisinopril	Lisinopril	103	35
Tamsulosin Hcl	Tamsulosin Hcl	97	31
Hydralazine Hcl	Hydralazine Hcl	92	25
Trazodone Hcl	Trazodone Hcl	87	15
Hydrochlorothiazide	Hydrochlorothiazide	81	29
Lactulose	Lactulose	81	24
Montelukast Sodium	Montelukast Sodium	78	22
Cefdinir	Cefdinir	68	56
Allopurinol	Allopurinol	65	suppressed
Ozempic	Semaglutide	65	16
Tramadol Hcl	Tramadol Hcl	65	43
Eliquis	Apixaban	63	22
Mirtazapine	Mirtazapine	59	19
Bumetanide	Bumetanide	57	12
Jardiance	Empagliflozin	57	16
Alendronate Sodium	Alendronate Sodium	55	13
Janumet	Sitagliptin Phos/Metformin Hcl	53	suppressed
Carvedilol	Carvedilol	52	19
Raloxifene Hcl	Raloxifene Hcl	52	20
Levetiracetam	Levetiracetam	50	14
Nifedipine Er	Nifedipine	50	15
Potassium Chloride	Potassium Chloride	49	15
Carbidopa-Levodopa	Carbidopa/Levodopa	46	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	43	16
Spironolactone	Spironolactone	41	11
Midodrine Hcl	Midodrine Hcl	39	11
Azithromycin	Azithromycin	38	35
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Januvia	Sitagliptin Phosphate	38	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	18
Zolpidem Tartrate	Zolpidem Tartrate	37	11
Ezetimibe	Ezetimibe	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	25
Finasteride	Finasteride	34	suppressed
Baclofen	Baclofen	33	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Alprazolam	Alprazolam	31	11
Simvastatin	Simvastatin	31	suppressed
Latanoprost	Latanoprost	30	suppressed
Amantadine	Amantadine Hcl	29	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	29	12
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Acetaminophen-Codeine	Acetaminophen With Codeine	25	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	17
Xifaxan	Rifaximin	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Clonidine	Clonidine	21	suppressed
Linzess	Linaclotide	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Primidone	Primidone	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Clonidine Hcl	Clonidine Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Cyproheptadine Hcl	Cyproheptadine Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Valsartan	Valsartan	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	14
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Omeprazole	Omeprazole	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	11
Famotidine	Famotidine	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Budesonide	Budesonide	16	suppressed
Cephalexin	Cephalexin	16	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Sulfasalazine	Sulfasalazine	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	14	suppressed
Enulose	Lactulose	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Novolin R	Insulin Regular, Human	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Prednisone	Prednisone	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error